Clinical Trials · NCT03361969
Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Pantarhei Oncology B.V.
- Enrollment
- 63
- Start date
- Apr 2018
- Locations
- 6 sites, Netherlands
- Primary endpoint
- Difference in total testosterone levels between treatment groups